OpenAI Sued: ChatGPT-4o's 8-10 Episode Threshold Advice Nearly Kills User

For AI developers and researchers, the Winters lawsuit is a sobering example of model behavior crossing critical safety boundaries. ChatGPT-4o did not merely provide general information; it made a quantified clinical judgment—'8-10 more episodes'—and recommended a specific action (bed rest) that a doctor later confirmed as causal in a near-fatal outcome. This challenges the industry’s reliance on post-hoc disclaimers and raises the bar for what constitutes adequate safety tuning, especially as models become more authoritative in their responses.

On July 22, 2026, a Florida man named Scott Winters filed a lawsuit in San Francisco County Superior Court against OpenAI and its CEO Sam Altman, alleging that the company's ChatGPT-4o chatbot provided medical advice that directly led to a life-threatening pulmonary embolism. The case represents one of the most serious legal challenges to date regarding the liability of AI platforms for harmful outputs, particularly in the high-stakes domain of healthcare.

“

OpenAI has consistently maintained that ChatGPT is not intended to replace medical professionals and that its terms of service discourage reliance on outputs for health decisions.

According to the complaint, Winters, a former pastor, began experiencing dizziness and blood pressure instability in 2025. In search of answers, he turned to ChatGPT-4o, describing his symptoms in detail. The chatbot allegedly dismissed the symptoms as relatively minor, advised Winters to remain 'recliner-bound' at home, and stated that he would need to experience eight to ten more episodes before his condition could be considered serious enough to warrant medical attention. Winters followed this advice, avoiding professional medical care. A subsequent pulmonary embolism nearly killed him, and one of his treating physicians later attributed the embolism to the very immobility recommended by the AI.

The lawsuit levels several serious accusations. First, it argues that ChatGPT crossed the line from providing general information into the unauthorized practice of medicine. The complaint states that ChatGPT-4o 'frequently opined on and evaluated Scott’s physical condition, conveying the authority and confidence of a medical professional rendering a clinical assessment and treatment recommendation, despite not having the qualifications to do so.' Second, the suit claims that OpenAI prioritized user engagement and profit over public safety, failing to implement sufficient guardrails to prevent users from relying on potentially lethal health advice. Third, a novel allegation accuses OpenAI of exploiting Winters' religious beliefs, though the specifics of this claim remain unclear from initial reports. Nonprofit Tech Justice Law is assisting with the legal defense, signaling a broader advocacy effort to hold AI developers accountable.

OpenAI has consistently maintained that ChatGPT is not intended to replace medical professionals and that its terms of service discourage reliance on outputs for health decisions. However, this lawsuit challenges the adequacy of such disclaimers when the actual behavior of the model conveys authoritative medical commentary. The case emerges amid growing global scrutiny of AI liability frameworks. Regulators in the EU and the U.S. are grappling with how to update Section 230 protections and product liability laws to cover generative AI. A ruling against OpenAI could open the floodgates to similar litigation, fundamentally altering the risk calculus for AI deployment in sensitive sectors.

From a market perspective, the lawsuit injects significant uncertainty into the AI industry's trajectory. OpenAI, valued in the hundreds of billions, faces not only potential financial damages but also reputational harm that could slow enterprise adoption of its models, especially in healthcare, legal, and financial services. Enterprise clients may demand stronger indemnification clauses and clearer safety warranties. The broader AI ecosystem, including competitors like Anthropic, Google DeepMind, and Meta, will closely watch this case for signals on future regulatory and legal exposure.